Transforming growth factor-β1 increases bad phosphorylation and protects neurons against damage

被引:223
|
作者
Zhu, Y
Yang, GY
Ahlemeyer, B
Pang, L
Che, XM
Culmsee, C
Klumpp, S
Krieglstein, J
机构
[1] Univ Marburg, Inst Pharmakol & Toxikol, D-35032 Marburg, Germany
[2] Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany
[3] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
来源
JOURNAL OF NEUROSCIENCE | 2002年 / 22卷 / 10期
关键词
TGF-beta; 1; neuroprotection; MAPK/Erk signaling; Bad phosphorylation; cerebral ischemia; rat hippocampal cells;
D O I
10.1523/JNEUROSCI.22-10-03898.2002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Despite the characterization of neuroprotection by transforming growth factor-beta1 (TGF-beta1), the signaling pathway mediating its protective effect is unclear. Bad is a proapoptotic member of the Bcl-2 family and is inactivated on phosphorylation via mitogen-activated protein kinase (MAPK). This study attempted to address whether MAPK signaling and Bad phosphorylation were influenced by TGF-beta1 and, furthermore, whether these two events were involved in the antiapoptotic effect of TGF-beta1. We found a gradual activation of extracellular signal-regulated kinase 1/2 (Erk1/2) and MAPK-activated protein kinase-1 (also called Rsk1) and a concomitant increase in Bad phosphorylation at Ser(112) in mouse brains after adenovirus-mediated TGF-beta1 transduction under nonischemic and ischemic conditions induced by transient middle cerebral artery occlusion. Consistent with these effects, the ischemia-induced increase in Bad protein level and caspase-3 activation were suppressed in TGF-beta1-transduced brain. Consequently, DNA fragmentation, ischemic lesions, and neurological deficiency were significantly reduced. In cultured rat hippocampal cells, TGF-beta1 inhibited the increase in Bad expression caused by staurosporine. TGF-beta1 concentration- and time-dependently activated Erk1/2 and Rsk1 accompanied by an increase in Bad phosphorylation. These effects were blocked by U0126, a mitogen-activated protein kinase/Erk kinase 1/2 inhibitor, suggesting an association between Bad phosphorylation and MAPK activation. Notably, U0126 and a Rsk1 inhibitor (Ro318220) abolished the neuroprotective activity of TGF-beta1 in staurosporine-induced apoptosis, indicating that activation of MAPK is necessary for the antiapoptotic effect of TGF-beta1 in cultured hippocampal cells. Together, we demonstrate that TGF-beta1 suppresses Bad expression under lesion conditions, increases Bad phosphorylation, and activates the MAPK/Erk pathway, which may contribute to its neuroprotective activity.
引用
收藏
页码:3898 / 3909
页数:12
相关论文
共 50 条
  • [31] Mandibular reconstruction with transforming growth factor-β1
    Sherris, DA
    Murakami, CS
    Larrabee, WF
    Bruce, AG
    LARYNGOSCOPE, 1998, 108 (03): : 368 - 372
  • [32] Transforming growth factor-β1 and prostate cancer
    Wikström, P
    Bergh, A
    Damber, JE
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2000, 34 (02): : 85 - 94
  • [33] Transforming growth factor-β1 in intrauterine adhesion
    Abudukeyoumu, Ayitila
    Li, Ming-Qing
    Xie, Feng
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2020, 84 (02)
  • [34] Transforming growth factor-β1 induces transforming growth factor-β1 and transforming growth factor-β receptor messenger RNAs and reduces complement C1qB messenger RNA in rat brain microglia
    Morgan, TE
    Rozovsky, I
    Sarkar, DK
    Young-Chan, CS
    Nichols, NR
    Laping, NJ
    Finch, CE
    NEUROSCIENCE, 2000, 101 (02) : 313 - 321
  • [35] Latency-associated Peptide of Transforming Growth Factor-β1 Is Not Subject to Physiological Mannose Phosphorylation
    Barnes, Jarrod
    Warejcka, Debra
    Simpliciano, Jennifer
    Twining, Sally
    Steet, Richard
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (10) : 7526 - 7534
  • [36] Transforming growth factor-β increases interleukin-6 transcripts in osteoblasts
    Franchimont, N
    Rydziel, S
    Canalis, E
    BONE, 2000, 26 (03) : 249 - 253
  • [37] Transforming growth factor-β and breast cancer -: Tumor promoting effects of transforming growth factor-β
    Dumont, N
    Arteaga, CL
    BREAST CANCER RESEARCH, 2000, 2 (02): : 125 - 132
  • [38] Smoking increases serum levels of transforming growth factor-β in diabetic patients
    Esmatjes, E
    Flores, L
    Lario, S
    Clària, J
    Cases, A
    Iñigo, P
    Campistol, JM
    DIABETES CARE, 1999, 22 (11) : 1915 - 1916
  • [39] Small molecular inhibitor of transforming growth factor-β protects against development of radiation-induced lung injury
    Bahl, Amit
    Sharma, Daya N.
    Rath, Gaura K.
    Julka, Pramod K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (02): : 630 - 630
  • [40] Small molecular inhibitor of transforming growth factor-β protects against development of radiation-induced lung injury
    Anscher, Mitchell S.
    Thrasher, Bradley
    Zgonjanin, Larisa
    Rabbani, Zahid N.
    Corbley, Michael J.
    Fu, Kai
    Sun, Lihong
    Lee, Wen-Cherng
    Ling, Leona E.
    Vujaskovic, Zeljko
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (03): : 829 - 837